| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/04/1993 | US5208244 Method of selectively inhibiting calcium-independent myocardial phospholipase A2 |
| 05/04/1993 | US5208243 Analgesics |
| 05/04/1993 | US5208241 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
| 05/04/1993 | US5208240 8-substituted purines as selective adenosine receptor agents |
| 05/04/1993 | US5208238 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| 05/04/1993 | US5208233 Cardiovascular disorders |
| 05/04/1993 | US5208227 Method, compositions, and compounds for modulating brain excitability |
| 05/04/1993 | US5208226 Administering salmeterol or salt and beclomethasone dipropionate as inhalant for respiratory system disorders |
| 05/04/1993 | US5208225 Compositions containing fixed combinations |
| 05/04/1993 | US5208222 Anthelemetic |
| 05/04/1993 | US5208221 Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
| 05/04/1993 | US5208035 Water Soluble Polymer Base, Penetration Enhancing Agent |
| 05/04/1993 | US5208032 Increasing the growth of turkeys using implant of 19-nortestosterone |
| 05/04/1993 | US5208031 Sexual lubricants containing zinc as an anti-viral agent |
| 05/04/1993 | US5208020 Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 05/04/1993 | US5208015 Topical anti-fungal agents having anti-inflammatory activity |
| 05/04/1993 | US5208012 Phenolic triazine |
| 05/04/1993 | CA1317302C N-1 substituted .beta.-lactams as antibiotics |
| 05/04/1993 | CA1317298C Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
| 05/04/1993 | CA1317296C Cardioprotective agent and a therapeutic agent for ischemic disease comprising n-containing heterocyclic compounds, and a process for the preparation of the same compounds |
| 05/04/1993 | CA1317293C Substituted 3-phenyl-7h-thiazolo[3,2-b][1,2,4]triazin-7- ones, a process for the preparation thereof, medicaments containing same and the use thereof, and also some intermediates formed in the preparation of the compounds mentioned |
| 05/04/1993 | CA1317292C Derivatives of (1-hydroxy-2-piperidylalkyl)-indol-2-ones, 2-quinolinones, 2-benzo[b]azapinones, benzimidazol-2-ones, and quinazolin-2-ones, their preparation and their applicationin therapeutics |
| 05/04/1993 | CA1317290C 4'-deshydroxyepipodophyllotoxin glucosides: synthesis and use |
| 05/04/1993 | CA1317230C Aqueous preparation of 9-methyl-3-(1h-tetrazol-5-yl)- 4h-pyrido ¬1,2-a|pyrimidin-4-one potassium salt |
| 05/04/1993 | CA1317229C Agent with an antidepressant activity |
| 05/04/1993 | CA1317228C Pharmaceutical preparation containing b-blocker and a potassium channel activator |
| 05/04/1993 | CA1317227C Composition of matter containing polycarbophil |
| 05/04/1993 | CA1317225C Use of adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
| 05/04/1993 | CA1317224C Method and composition for the treatment and prevention of viral infections |
| 05/02/1993 | CA2081847A1 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
| 05/02/1993 | CA2081811A1 Butyric acid derivatives |
| 05/01/1993 | WO1993008847A1 Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer |
| 05/01/1993 | CA2081819A1 Phthalazines containing an ether or thioether group in the 1-position and a process for their preparation |
| 05/01/1993 | CA2081674A1 Heterocyclic compounds |
| 04/30/1993 | WO1993009087A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/30/1993 | CA2115847A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/30/1993 | CA2081614A1 Fibrinogen receptor antagonists |
| 04/30/1993 | CA2081580A1 Water soluble camptothecin derivatives |
| 04/30/1993 | CA2081510A1 Alkaloids and processes for their production |
| 04/29/1993 | WO1993008361A1 Anti-explosion pads and their method of use |
| 04/29/1993 | WO1993008296A1 Oligonucleotides having chiral phosphorus linkages |
| 04/29/1993 | WO1993008206A1 Novel 2,6-disubstituted purine derivatives |
| 04/29/1993 | WO1993008197A1 Thienopyrazine-2,3-diones and their preparation and use |
| 04/29/1993 | WO1993008196A1 Penicillin g ester |
| 04/29/1993 | WO1993008195A1 Cyclic peroxyacetal compounds |
| 04/29/1993 | WO1993008193A1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 04/29/1993 | WO1993008192A1 Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
| 04/29/1993 | WO1993008190A1 Pyrrolo-pyridazines with gastro-intestinal protective action |
| 04/29/1993 | WO1993008188A1 Tricyclic quinoxalinediones as glutamate receptor antagonists |
| 04/29/1993 | WO1993008187A1 Imidazopyridines and indolizines as 5-ht4 antagonists |
| 04/29/1993 | WO1993008186A1 Pyridine-3-carboxylic acid esters or amides useful as 5-ht3 antagonists |
| 04/29/1993 | WO1993008184A1 Hiv protease inhibitors |
| 04/29/1993 | WO1993008182A1 Benzodioxane derivative |
| 04/29/1993 | WO1993008181A1 Cyclohexaneacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| 04/29/1993 | WO1993008179A1 Oxazolidone derivative |
| 04/29/1993 | WO1993008176A1 Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
| 04/29/1993 | WO1993008174A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR |
| 04/29/1993 | WO1993008173A1 Quinoxaline derivates with affinity for quisqualate-receptors |
| 04/29/1993 | WO1993008171A1 Pyrimidocycloalkanes as angiotensin ii antagonists |
| 04/29/1993 | WO1993008170A1 Substituted heterocycles as angiotensin ii antagonists |
| 04/29/1993 | WO1993008169A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | WO1993008166A1 Benzo-isoquinoline derivatives and analogs and their use in therapeutics |
| 04/29/1993 | WO1993008164A1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 04/29/1993 | WO1993008162A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 04/29/1993 | WO1993008158A1 2-(2,3-dicarboxycyclopropyl)glycine and method for producing the same |
| 04/29/1993 | WO1993008155A1 Lignan analog, production thereof, and hypolipidemic drug |
| 04/29/1993 | WO1993008120A1 2-aminopropan-1,3-diol chemotherapeutic agents |
| 04/29/1993 | WO1993007906A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | WO1993007904A1 Lipophilic oligosaccharide antibiotic salt compositions |
| 04/29/1993 | WO1993007902A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | WO1993007899A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
| 04/29/1993 | WO1993007886A1 Pharmaceutical composition containing certain peptidomimetic compounds |
| 04/29/1993 | WO1993007884A1 External preparation for treating hemorrhoidal diseases |
| 04/29/1993 | WO1993007881A1 Inhibition of viruses by the administration of homopolyribonucleotides and/or duplex polymers |
| 04/29/1993 | WO1993007875A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | WO1993007874A1 Medicament composition for topical application |
| 04/29/1993 | WO1993007873A1 Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
| 04/29/1993 | WO1993007872A1 Lysosomal enzyme inhibitors for the treatment of neurodegenerative diseases |
| 04/29/1993 | WO1993007871A1 Methods for the treatment of hyperlipidemia using azaspiranes |
| 04/29/1993 | WO1993007870A1 Device for the transdermal administration of melatonin |
| 04/29/1993 | WO1993007869A1 Methods for treatment of hyperlipidemia using azaspiranes |
| 04/29/1993 | WO1993007868A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 04/29/1993 | WO1993007867A1 SUBSTITUTED β-AMINO ACID DERIVATIVES USEFUL AS PLATELET AGGREGATION INHIBITORS |
| 04/29/1993 | WO1993007866A2 Compositions and methods for therapy and prevention of cancer, aids, and anemia |
| 04/29/1993 | WO1993007865A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 04/29/1993 | WO1993007864A1 Use of suramine and related compounds as contraceptive agents |
| 04/29/1993 | WO1993007863A1 Methods and compositions for treating allergic reactions |
| 04/29/1993 | WO1993007861A1 Preparation and uses of multi-phase microspheres |
| 04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 04/29/1993 | WO1993007847A1 Anti-seborrhoeic formulation |
| 04/29/1993 | WO1993007840A1 Enzyme-orthokeratology |
| 04/29/1993 | WO1993007751A1 Fungicides for the control of take-all disease of plants |
| 04/29/1993 | WO1993007748A2 Laser-based inhibition of smooth muscle cell hyperproliferation |
| 04/29/1993 | WO1993007747A1 Antimicrobial dialdehyde composition and methods of use |
| 04/29/1993 | WO1993004055A3 Compounds used for the inhibition of hiv-protease |
| 04/29/1993 | WO1993001165A3 Aromatic compounds, compositions containing them and their use in therapy |
| 04/29/1993 | CA2121900A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
| 04/29/1993 | CA2121845A1 Heterocyclic compounds and their preparations and use |
| 04/29/1993 | CA2121844A1 Novel 2,6-disubstituted purine derivatives |
| 04/29/1993 | CA2121838A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |